今天3分钟我们来聊聊干细胞治痴呆：鼻腔给药破血脑屏障

全球痴呆患者超5500万，现有药物治标不治本。干细胞具修复逆转潜力，间充质干细胞是主流。鼻腔给药无创且安全，可规避血脑屏障。研究显示能改善认知、延缓脑萎缩，但需更多III期试验验证。参考文献：Systematic review of stem cell therapy for dementia. International Journal of Emergency Medicine, 2026.Rash BG, et al. Phase II trial of laromestrocel in mild Alzheimer's disease. Nature Medicine.Phase I trial of stereotactic intracerebral mesenchymal stem cell injection in mild-to-moderate Alzheimer's disease. Alzheimer's & Dementia.ClinicalTrials.gov: NCT01297218, NCT02054208, NCT03724136, NCT04388982.前往小宇宙评论区与主播互动